Entera Bio
ENTX
9 hedge funds and large institutions have $4.85M invested in Entera Bio in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
6,367% more call options, than puts
Call options by funds: $194K | Put options by funds: $3K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.88% less ownership
Funds ownership: 17.07% → 16.19% (-0.88%)
10% less funds holding
Funds holding: 10 → 9 (-1)
26% less capital invested
Capital invested by funds: $6.54M → $4.85M (-$1.69M)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$50.4K |
| 2 |
Renaissance Technologies
New York
|
+$32.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$408K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$19.1K |
| 3 |
Millennium Management
New York
|
-$10.3K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$8.53K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KCM
1
Knoll Capital Management
Miami,
Florida
| $2.58M | – | – | – |
|
|
RCM
2
RA Capital Management
Boston,
Massachusetts
| $2.17M | -$408K | -270,628 | -12% |
|
|
3
Morgan Stanley
New York
| $38K | +$50.4K | +33,400 | +1,208% |
|
|
4
Renaissance Technologies
New York
| $22K | +$32.1K | +21,300 | New |
|
5
Geode Capital Management
Boston,
Massachusetts
| $18K | – | – | – |
|
|
6
Millennium Management
New York
| $10K | -$10.3K | -6,833 | -41% |
|
7
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $10K | – | – | – |
|
|
8
UBS Group
Zurich,
Switzerland
| $2K | -$8.53K | -5,650 | -76% |
|
9
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
10
Citadel Advisors
Miami,
Florida
| – | -$19.1K | -12,657 | Closed |
|
ENTX Hedge Fund Activity: Q3 2022 in Review
9 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q3 2022, worth a combined $4.85M — down 26% from $6.54M a quarter earlier.
Fund positioning in ENTX was balanced in Q3 2022: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $50.4K. The largest seller was RA Capital Management, cutting an estimated $408K.
- 9 institutional investors held Entera Bio (ENTX) as of Q3 2022, down from 10 in Q2 2022.
- Funds reported $4.85M of Entera Bio stock for Q3 2022, down 26% quarter-over-quarter.
- 1 fund opened new Entera Bio positions in Q3 2022 and 1 closed out, a net change of 0 holders.
- The largest Entera Bio buyer in Q3 2022 was Morgan Stanley, an estimated $50.4K added.
- The largest Entera Bio seller in Q3 2022 was RA Capital Management, an estimated $408K sold.
Based on aggregated 13F filings for Q3 2022.